Deep learning-based uncertainty quantification for quality assurance in hepatobiliary imaging-based techniquesSingh Y, Andersen JB, Hathaway Q, Venkatesh SK, Gores GJ, Erickson B
|
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomasOlaizola I, Odriozola-Gimeno M, Olaizola P, Caballero-Camino FJ, Pastor-Toyos N, Tena-Garitaonandia M, Lapitz A, Val B, Guimaraes AR, Asensio M, Huici-Izagirre M, Rae C, de Sancho D, Lopez X, Rodrigues PM, Herraez E, Briz O, Izquierdo-Sanchez L, Eleta-Lopez A, Bittner AM, Martinez-Amesti A, Miranda T, Ilyas SI, Braconi C, Perugorria MJ, Bujanda L, Rivilla I, Marin JJG, Cossio FP, Banales JM
|
Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysisAkkus E, Yasar HA, Rimassa L, Lamarca A
|
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trialsYoo C, Saborowski A, Hyung J, Wenzel P, Kim I, Wege H, Kim K, Folprecht G, Ryoo B, Schütt P, Cheon J, Götze T, Ryu H, Lee J, Vogel A
|
Deciphering the spatial tumor microenvironment in intrahepatic cholangiocarcinomaMacias RIR, Roessler S, Verstegen MMA
|